| A Study to Prepare for Future HIV Vaccine Studies (NCT00029744) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-04-01 |
| Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies (NCT00078195) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-04-01 |
| Analysis of Immune Responses to HIV Vaccines (NCT00068978) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-04-01 |
| When to Start Anti-HIV Drugs in Patients With Opportunistic Infections (NCT00055120) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-03-01 |
| Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics (NCT00057499) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-03-01 |
| Immunologic Control of Drug Resistant HIV (NCT00053404) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-03-01 |
| Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults (NCT00051454) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-03-01 |
| Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease (NCT00056355) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-03-01 |
| Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus (NCT00102934) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-03-01 |
| Immune Responses to Smallpox Vaccination (NCT00325975) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-02-04 |
| Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox (NCT00053742) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-02-01 |
| Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV (NCT00006441) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-02-01 |
| HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs (NCT00056758) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-02-01 |
| Screening HIV-Infected Patients for Vaccine Studies (NCT00051519) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-01-09 |
| Safety of RG2077 in Patients With Multiple Sclerosis (NCT00076934) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-01-01 |
| Alternative Dosing Strategy for Anti-HIV Drugs (NCT00059384) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-01-01 |
| Cause and Natural Course of Pediatric-Onset Mastocytosis (NCT00050193) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-11-22 |
| Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease (NCT00048789) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-11-04 |
| Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection (NCT00050856) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-11-01 |
| Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients (NCT00050310) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-31 |
| HIV-1 Vaccine Test in Uninfected Adult Volunteers (NCT00047931) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-17 |
| Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis (NCT00048347) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-01 |
| Growth Hormone to Increase Immune Function in People With HIV (NCT00071240) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-01 |
| Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing (NCT00047918) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-01 |
| Expanded Dryvax Dilution Study in Previously Vaccinated Adults (NCT00050505) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-01 |
| Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients (NCT00052182) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-01 |
| Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome (NCT00044304) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-09-26 |
| Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma (NCT00068146) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-09-19 |
| Study of Factors Regulating Mast Cell Proliferation (NCT00044122) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-09-18 |
| Tuberculosis Prevention for HIV Infected Adults (NCT00057122) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-09-01 |
| Phase I Trial of Smallpox Vaccine (NCT00046397) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-09-01 |
| Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda (NCT00339456) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-21 |
| Male Circumcision for HIV Prevention in Rakai, Uganda (NCT00425984) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-01 |
| HIV-1 Vaccine Test in Uninfected Adult Volunteers (NCT00045838) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-01 |
| Promoting Adherence to Anti-HIV Drug Regimens (NCT00051805) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-01 |
| Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children (NCT00039741) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-01 |
| Daily Nevirapine to Prevent Mother to Infant Transmission of HIV (NCT00061321) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-08-01 |
| HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART) (NCT00043641) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-07-26 |
| Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants (NCT00039689) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-07-12 |
| Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, Mali (NCT00341783) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-07-01 |
| ICC-1132 - Candidate Vaccine Against P Falciparum Malaria (NCT00587249) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-07-01 |
| Valganciclovir in Congenital CMV Infants (NCT00031434) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-07-01 |
| Antibody Production in Immune Disorders (NCT00023504) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-06-13 |
| Daclizumab to Treat Wegener's Granulomatosis (NCT00040248) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-06-01 |
| Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor (NCT00041769) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-06-01 |
| The Effect of Parasitic Worm Infections on the Immune Response to Tuberculosis Bacteria (NCT00342017) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-05-20 |
| Treatment With hOKT3gamma1(Ala-Ala) in T1DM (NCT00806572) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-05-01 |
| Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy (NCT00017719) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-05-01 |
| Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT (NCT00038987) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-05-01 |
| Genetic Studies of Chronic Active Epstein-Barr Disease (NCT00032513) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-04-16 |
| Posaconazole to Treat Invasive Fungal Infections (NCT00033982) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-04-11 |
| Tuberculosis Treatment Shortening Trial (NCT00130247) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-04-08 |
| HIV Prevention Preparedness Study in Russia, China, and India (NCT00021775) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-04-01 |
| Leprosy Skin Test Antigens Trial (NCT00128193) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-04-01 |
| Diagnosing Tuberculosis in HIV Infected Children in Peru (NCT00054769) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-03-01 |
| Treatment of Hepatitis C in Hemophilic Patients With HIV (NCT00055341) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-03-01 |
| Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients (NCT00028314) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-03-01 |
| Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV (NCT00056797) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-03-01 |
| Screening Protocol for HIV Vaccine Studies (NCT00031304) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-02-27 |
| Stem Cell Transplantation to Treat Leukocyte Adhesion Deficiency (NCT00031005) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-02-01 |
| The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin (NCT00031343) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-02-01 |
| Male Circumcision and HIV Rates in Kenya (NCT00059371) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-02-01 |
| Evaluation, Treatment, and Follow-up of Patients With Lyme Disease (NCT00028080) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-01-16 |
| Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants (NCT00385632) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-01-01 |
| Pentoxifylline in Children With Malaria (NCT00133393) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-01-01 |
| Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants (NCT00386035) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-01-01 |
| Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID) (NCT00028236) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-12-10 |
| Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers (NCT00027482) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-12-04 |
| Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis (NCT00029107) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-12-01 |
| Diagnosis and Treatment of Leishmania Infections (NCT00344188) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-11-30 |
| Treatment of Multiple Sclerosis With Copaxone and Albuterol (NCT00039988) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-11-01 |
| G-CSF to Treat Crohn's Disease (NCT00025805) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-10-23 |
| Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load (NCT00025922) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-10-01 |
| Impact of Gender on Patients (NCT00170560) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-10-01 |
| Intermittent vs. Continuous HAART to Treat Chronic HIV Infection (NCT00025909) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-10-01 |
| Funguria in Hospitalized Patients (NCT00138502) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-09-17 |
| Neonatal CMV-Ganciclovir Follow-up Study (NCT00031421) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-09-01 |
| Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia (NCT00034528) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-09-01 |
| Zidovudine Levels in HIV Infected Patients Being Treated for HCV (NCT00059358) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-09-01 |
| Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors (NCT00029445) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-08-09 |
| Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs (NCT00016718) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-08-01 |
| Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care (NCT00023192) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-08-01 |
| Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection (NCT00023153) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-08-01 |
| Surveillance of Streptococcal Infections in Children in India (NCT00342199) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-07-03 |
| A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections (NCT00021567) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-07-01 |
| Pleconaril Enteroviral Sepsis Syndrome (NCT00031512) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-06-27 |
| Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome (NCT00017862) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-06-01 |
| Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients (NCT00018031) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-06-01 |
| Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women (NCT00016601) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-06-01 |
| Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs (NCT00017771) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-06-01 |
| Identification of Viruses Associated With Diseases of Unknown Cause (NCT00359268) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-05-08 |
| Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2 (NCT00050726) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-05-01 |
| Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms (NCT00015431) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-04-16 |
| Islet Transplantation for Type 1 Diabetes (NCT00014911) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-04-01 |
| Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People (NCT00053430) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-04-01 |
| Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections (NCT00015665) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-04-01 |
| Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients (NCT00013702) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-03-01 |
| Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers (NCT00005762) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-03-01 |
| Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome (NCT00013689) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-03-01 |
| Racial Difference in HCV/Host Interactions (NCT00071916) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-03-01 |